BioLineRx Ltd. Analysis
| Analyst Ratings |
|
Average Target Price
|
9.67
|
|
Average Rating
|
4.50
|
|
# Strong Buys
|
1
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.13
|
0.00
|
0.13
|
100.00%
|
|
2022-12-31
|
-0.15
|
0.00
|
0.15
|
100.00%
|
|
2022-09-30
|
-0.16
|
-0.01
|
0.15
|
93.75%
|
|
2022-06-30
|
-0.11
|
-0.15
|
-0.04
|
-36.36%
|
|
2022-03-31
|
-0.09
|
-0.15
|
-0.06
|
-66.67%
|
|
2021-12-31
|
-0.14
|
-0.10
|
0.04
|
28.57%
|
|
2021-09-30
|
-0.16
|
-0.15
|
0.01
|
6.25%
|
|
2021-06-30
|
-0.15
|
-0.15
|
0.00
|
0.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.31
|
|
2021-12-31
|
-0.70
|
|
2020-12-31
|
-1.95
|
|
2019-12-31
|
-2.70
|
|
2018-12-31
|
-3.15
|
|
2017-12-31
|
-3.08
|
|
2016-12-31
|
-0.28
|
|
2015-12-31
|
-0.29
|
|
2014-12-31
|
-1.65
|
|
2013-12-31
|
-9.15
|
|
2012-12-31
|
-17.67
|
|
2011-12-31
|
-7.34
|